OpenVSafe by OpenVAERS
Search V-safe

XWY-88256-44517

5 vaccinations 18 coded responses 42 check-ins 17 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
953 / CA
Registered
2021-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-07
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-23
    Registered in v-safe
  4. 2021-12-23
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-23
    Health check-in — 0 day, dose 3
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-12-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Eye pain — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  7. 2021-12-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  8. 2021-12-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hypoglycaemia — Feeling: Fair · Fever · Chills, Headache, Joint pains
    MedDRA releases: 2024-11 · check-in answers available
  9. 2021-12-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Joint pains
    Adult check-in
  10. 2021-12-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hypoglycaemia — Feeling: Good · Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  11. 2021-12-30
    Health check-in — 7 day, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2022-01-06
    Health check-in — 14 day, dose 3
    Feeling: Good
    Adult check-in
  13. 2022-01-13
    Health check-in — 21 day, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-01-20
    Health check-in — 28 day, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-27
    Survey response — 35 day, dose 3
    MedDRA: Conjunctivitis — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  16. 2022-02-04
    Health check-in — 42 day, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-03-26
    Health check-in — 3 month, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-05-06
    Dose 4 — Pfizer-BioNTech
  19. 2022-05-06
    Survey response — 0 day, dose 4
    MedDRA: Musculoskeletal stiffness — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  20. 2022-05-07
    Survey response — days 1–6 daily, dose 4
    MedDRA: Arthralgia, Eye irritation, Neck pain, Pain in extremity — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  21. 2022-05-08
    Survey response — days 1–6 daily, dose 4
    MedDRA: Decreased appetite, Photophobia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  22. 2022-05-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  23. 2022-05-10
    Survey response — days 1–6 daily, dose 4
    MedDRA: Asthma, Cough — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  24. 2022-05-11
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Joint pains, Muscle or body aches
    Adult check-in
  25. 2022-05-12
    Survey response — days 1–6 daily, dose 4
    MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Diarrhea
    MedDRA releases: 2024-11 · check-in answers available
  26. 2022-05-13
    Survey response — 7 day, dose 4
    MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Headache, Joint pains, Muscle or body aches
    MedDRA releases: 2024-11 · check-in answers available
  27. 2022-05-20
    Survey response — 14 day, dose 4
    MedDRA: Acne — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  28. 2022-05-28
    Health check-in — 21 day, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-06-03
    Health check-in — 28 day, dose 4
    Feeling: Good
    Adult check-in
  30. 2022-06-11
    Survey response — 35 day, dose 4
    MedDRA: Blood pressure increased, Heart rate increased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11 · check-in answers available
  31. 2022-06-11
    Report sent to call center — 35 day, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  32. 2022-06-13
    Call successful
    Participant prefers to complete VAERS report online
  33. 2022-06-19
    Health check-in — 42 day, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-08-06
    Health check-in — 3 month, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-09-17
    Dose 5 — Pfizer-BioNTech
  36. 2022-09-17
    Survey response — 0 day, dose 5
    MedDRA: Burning sensation, Immediate post-injection reaction — Feeling: Good · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  37. 2022-09-18
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  38. 2022-09-19
    Survey response — days 1–6 daily, dose 5
    MedDRA: Asthma, Cough — Feeling: Good · Site: Pain · Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  39. 2022-09-20
    Health check-in — days 1–6 daily, dose 5
    Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  40. 2022-09-21
    Survey response — days 1–6 daily, dose 5
    MedDRA: Asthma, Cough — Feeling: Good · Site: Pain · Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  41. 2022-09-22
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness
    Adult check-in
  42. 2022-09-23
    Survey response — days 1–6 daily, dose 5
    MedDRA: Muscular weakness — Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  43. 2022-09-24
    Health check-in — 7 day, dose 5
    Feeling: Fair · Headache
    Adult check-in
  44. 2022-10-01
    Survey response — 14 day, dose 5
    MedDRA: Hot flush — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  45. 2022-10-09
    Health check-in — 21 day, dose 5
    Feeling: Good
    Adult check-in
  46. 2022-10-16
    Health check-in — 28 day, dose 5
    Feeling: Good
    Adult check-in
  47. 2022-10-24
    Health check-in — 35 day, dose 5
    Feeling: Good
    Adult check-in
  48. 2022-10-31
    Health check-in — 42 day, dose 5
    Feeling: Good
    Adult check-in
  49. 2022-12-18
    Health check-in — 3 month, dose 5
    Feeling: Good
    Adult check-in
  50. 2023-03-18
    Survey response — 6 month, dose 5
    MedDRA: Blood magnesium increased, Blood potassium increased, Hypoaesthesia, Paraesthesia, Raynaud's phenomenon — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11 · check-in answers available
  51. 2023-03-18
    Report sent to call center — 6 month, dose 5
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  52. 2023-03-20

Vaccinations

DoseDateManufacturerCo-administered
12021-04-16Pfizer-BioNTech No
22021-05-07Pfizer-BioNTech No
32021-12-23Pfizer-BioNTech No
42022-05-06Pfizer-BioNTech No
52022-09-17Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-06-11 Successful
2022-06-13
Participant prefers to complete VAERS report online
2023-03-18 Unsuccessful

Free text

Release 10

Systemic reaction (other): Eye pain

Systemic reaction (other): Hypoglycemia

Systemic reaction (other): Still getting hypoglycemia since my shot

Release 11

Symptoms: pinkeye

Systemic reaction (other): Stiff neck - same side as the injection

Systemic reaction (other): Bottom of left foot pain, neck/shoulder pain, eye irritation

Systemic reaction (other): light sensitivity, no appetite

Systemic reaction (other): Asthma attack, coughing - this has happened after all 4 Pfizer shots

Systemic reaction (other): Increased asthma ever since the shot. Happened after every shot. Mirrors the fact that my asthma got worse after actual Covid in 2020.

Systemic reaction (other): Still dealing with increased asthma since getting the shot.

Symptoms: pimply cluster on left wrist

Release 12

Symptoms: High pulse 136 / BP spike 155/89

Systemic reaction (other): A burning rash-like feeling developed on my upper back an hour after injection but there was no physical rash present.

Systemic reaction (other): Coughing/asthma

Systemic reaction (other): increased asthma, slight cough

Systemic reaction (other): Arm & leg weakness

Symptoms: My hot flashes returned.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAcne · · ✓
SDBlood magnesium increased · · ✓
SDBlood potassium increased · · ✓
SDBlood pressure increased · · ✓
SDConjunctivitis · · ✓
SDHeart rate increased · · ✓
SDHot flush · · ✓
SDHypoaesthesia · · ✓
SDParaesthesia · · ✓
SDRaynaud's phenomenon · · ✓
SROArthralgia · · ✓
SROAsthma · · ✓
SROBurning sensation · · ✓
SROCough · · ✓
SRODecreased appetite · · ✓
SROEye irritation · · ✓
SROEye pain · · ✓
SROHypoglycaemia · · ✓
SROImmediate post-injection reaction · · ✓
SROMuscular weakness · · ✓
SROMusculoskeletal stiffness · · ✓
SRONeck pain · · ✓
SROPain in extremity · · ✓
SROPhotophobia · · ✓
SROPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release